Rhode Island S2877 caps the cost of insulin administration and glucose monitoring equipment at $25 per 30-day supply, effective January 1, 2027.

Rhode Island S2877 mandates that health insurance plans in the state cover equipment and supplies for insulin administration and glucose monitoring, with a cap on the amount a covered person must pay at $25 per 30-day supply or per item for supplies intended for longer than 30 days. This cap will take effect on January 1, 2027. The bill also ensures that coverage for these supplies is not subject to any annual deductible. If applying the cap before meeting the deductible would disqualify a person from a health savings account, the cap would only apply after the deductible is met.

Rhode Island S2877 caps the cost of insulin administration and glucose monitoring equipment at $25 per 30-day supply, effective January 1, 2027.

Rhode Island S2877 mandates that health insurance plans in the state cover equipment and supplies for insulin administration and glucose monitoring, with a cap on the amount a covered person must pay at $25 per 30-day supply or per item for supplies intended for longer than 30 days. This cap will take effect on January 1, 2027. The bill also ensures that coverage for these supplies is not subject to any annual deductible. If applying the cap before meeting the deductible would disqualify a person from a health savings account, the cap would only apply after the deductible is met.